SCHEMBL28373345

SCHEMBL28373345

Cc1cc(C)c(P(c2c(C)cc(C)cc2C)c2c(F)c(F)cc(F)c2F)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RAPGEF4 Q8WZA2 7/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL301709 0.81 RAPGEF4 (0.43) RAPGEF4
SCHEMBL15077511 0.79 RAPGEF4 (0.43) RAPGEF4
SCHEMBL16862694 0.79 RAPGEF4 (0.32) RAPGEF4
Silver SCHEMBL31010581 0.78 RAPGEF4 (0.41) RAPGEF4
SCHEMBL31325570 0.78 RAPGEF4 (0.41) RAPGEF4
SCHEMBL8773546 0.78 RAPGEF4 (0.41) RAPGEF4
Bromide SCHEMBL3679642 0.78 RAPGEF4 (0.41) RAPGEF4
Iodide SCHEMBL9662368 0.78 RAPGEF4 (0.41) RAPGEF4
SCHEMBL15825735 0.76 RAPGEF4 (0.34) RAPGEF4
SCHEMBL8268053 0.71 RAPGEF4 (0.52) RAPGEF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116813596-A Macrocyclic HCV NS3 inhibits tripeptide synthesis 吉利德科学公司 2023-09-29 CN disclosed
CN-111320610-B Macrocyclic HCV NS3 inhibits tripeptide synthesis 吉利德科学公司 2023-06-06 CN disclosed
CN-111320610-A Macrocyclic HCV NS3 inhibits the synthesis of tripeptides 吉利德制药有限责任公司 2020-06-23 CN disclosed
CN-105849118-B Macrocyclic HCV NS3 inhibits the synthesis of tripeptides 吉利德制药有限责任公司 2020-03-31 CN disclosed